Delivery Order SPE2DB24D1006-SPE2DB25FCFAS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,241.46 to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules (100-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules in quantities of 100 units with a ceiling value of $1,337.70. This competitively awarded, non-set-aside contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The delivery order employs firm fixed pricing and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $17.4K delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (40mg) under a firm fixed-price contract. The delivery order, issued on August 5, 2025, represents a non-competitive, competitively awarded transaction with a completion deadline of August 6, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery....
- The Defense Logistics Agency awarded a $3,073.28 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Vyvanse 40 mg capsules (100 count) with a completion date of August 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse 60 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,367.16. The award, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a competitive procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse 60 mg capsules (100-count units) under a firm fixed-price contract valued at $1,143.98. The delivery order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a non-competitive award to the prime contractor. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse 40 mg capsules (100-count) under a firm fixed-price contract with a ceiling value of $1,441.94. The contract was competitively awarded without a set-aside designation and is scheduled for completion by July 29, 2025. AmerisourceBergen will perform work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse 40 mg capsules (100 count) with a ceiling value of $3,878.02. This competitively awarded, firm fixed price contract was issued on August 1, 2025, with an ultimate completion date of August 4, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside award, this contract was competed among qualified vendors in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Vyvanse 30 mg capsules (100-count) with a contract value of $2,117.56 and completion date of July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract valued at $2,662.44 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 100 units of Vyvanse 40 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
- SPE2DB24D1006Indefinite Delivery Contract
- SPE2DB24D1006-SPE2DB25FCFASDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse 40 mg capsules (100-count units) under a firm fixed-price contract valued at $1,710.69. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of August 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its Corporate Office location at that same address. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs and other federal medical procurement needs. This contract represents part of the Defense Logistics Agency's pharmaceutical prime vendor program, which is designed to provide flexible, competitively awarded contracting mechanisms for federal healthcare system supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/20/25 |